Dolphin Vision provides advanced air freshener systems designed to neutralise airborne viral pathogens in commercial and public indoor spaces. Its flagship product, Arothera, is a barely noticeable device that utilises gentle therapeutic diffusion of all-natural, plant-based aroma blends. This proprietary combination of natural ingredients actively destroys aerobic pathogens in the air, offering a continuous method of facility protection against infection. The system targets a wide range of common airborne diseases, including Influenza, COVID-19, Avian Flu, and Tuberculosis, significantly reducing the risk of illness. By proactively neutralising viruses and providing a pleasant, fragrant environment, Dolphin Vision enables employees and clients to feel safe returning to offices and clinics. The solution is efficient and scalable, with large-scale modules capable of covering extensive facilities such as open-plan offices, hotels, and transit hubs.
Cumulative Funding Raised Over Time ($)
Employees Over Time
Dolphin Vision Climate Tech relevance
null
Latest News
No Data, yet.
Sorry, no content found under this section.
Jun 21, 2022
www.youtube.com
Covid19 forecast 2022-2023 i24TV interview French
undefined
Jan 7, 2022
beststartup.asia
18 Top Israeli Public Transportation Companies and Startups
#Customers #Partners
Apr 3, 2021
startup.info
Gennady Simanovsky, CEO & founder of Dolphin Vision on Covid